Student: Dr. Einstein, aren't these the same questions as last year's final exam?Dr. Einstein: Yes, but this year the answers are different.Over the past two decades, catheter ablation for atrial fibrillation (AF) has come full circle. After the seminal observation that AF may be triggered by a focal source, and that elimination of that source could cure AF, multiple additional ablation strategies have been advocated including ablation of complex electrograms, linear left atrial ablation, focal source/rotor ablation, and ablation targeting low‐voltage regions. All these strategies seek to reduce the recurrence rate of AF following ablation and the proportion of patients, perhaps as high as 50%, requiring repeat ablation. The large, multicenter STAR AF II trial in patients with persistent AF tested two of these additional strategies (complex fractionated atrial ablation and linear ablation) and returned the field to where it began: isolate the pulmonary veins, and isolate them effectively.Correspondingly, over recent years there has been increasing and appropriate focus on procedural techniques to improve the formation of durable, transmural, and contiguous atrial radiofrequency (RF) ablation lesions, as well as assessment techniques to quantify such lesions. Although future catheter technologies may enable real‐time visualization of ablation lesions, this is not
Journal of Cardiovascular Electrophysiology – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera